Last verified: April 2026
What the Harris Rider Does
The Harris Rider is a provision inserted into the federal appropriations bill — the must-pass spending legislation that funds the government — that bars the District of Columbia from using any funds whatsoever to:
- Enact any law to legalize or otherwise reduce penalties associated with Schedule I controlled substances
- Enact any law regarding THC derivatives
- Spend local or federal funds on implementing, regulating, or taxing cannabis sales
The critical detail: the rider blocks DC from spending even its own locally raised tax revenue. Unlike federal grant restrictions that limit how federal dollars are used, this provision reaches into DC's own treasury and forbids the city from using money its residents paid in taxes to enact cannabis regulations.
None of the funds contained in this Act may be used to enact any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act or any tetrahydrocannabinol derivative.
Harris Rider Language — Federal Appropriations
The Man Behind the Rider
Andy Harris represents Maryland's 1st Congressional District — the Eastern Shore and parts of northeast Maryland. He is a practicing anesthesiologist, former chairman of the House Freedom Caucus, and currently chairs the Agriculture Appropriations subcommittee, which gives him direct control over spending provisions affecting DC.
Harris first inserted the rider into the December 2014 omnibus spending bill, just weeks after DC voters approved Initiative 71. The timing was deliberate: Congress used its authority over DC's budget to nullify the policy implications of a democratic vote before the law even took effect.
The deepest irony is geographic. Harris represents a state — Maryland — that has built a $1.16 billion annual legal cannabis market with full taxation and regulation. Maryland dispensaries operate openly across the state, including in Harris's own district on the Eastern Shore. His rider ensures that the people living next door in Washington, DC cannot have the same system his own constituents enjoy.
Rep. Harris's Maryland constituents can walk into any of dozens of dispensaries and buy regulated, tested cannabis. Taxpayers in his state benefit from cannabis tax revenue. Meanwhile, his rider ensures 700,000 DC residents live in a market with zero regulation, zero testing for recreational products, zero tax revenue, and a $600 million underground gifting economy.
The Fight to Remove It
Every year, a coalition of DC leaders, congressional allies, and advocacy groups fights to strip the Harris Rider from the spending bill. Every year, they lose.
Delegate Eleanor Holmes Norton, DC's non-voting representative in Congress, has led the effort relentlessly. Norton has introduced standalone legislation, amendment proposals, and procedural maneuvers to eliminate the rider. She has been joined by Democratic members on the Appropriations Committee and cannabis reform advocates nationwide.
The closest the rider came to falling was in June 2024, when the House Appropriations Committee's initial draft of the spending bill omitted the rider entirely. For a brief period, DC advocates believed the decade-long blockade might end. It was reinstated before the bill reached the floor.
The most recent renewal came on January 15, 2026, when the House passed the spending bill 341–79 with the Harris Rider intact. President Trump signed the bill on February 4, 2026. The overwhelming margin — and bipartisan support — demonstrates how deeply embedded the rider has become in the annual spending process.
Why the Rider Keeps Surviving
The Harris Rider persists for reasons that have little to do with cannabis policy and everything to do with Washington's political architecture:
- DC has no voting representation in Congress. Delegate Norton can speak on the House floor but cannot vote. DC has no senators at all. The 700,000 people affected by the rider have no electoral leverage over the members who renew it.
- The rider is buried in must-pass legislation. Appropriations bills fund the entire federal government. No member of Congress is going to shut down the government over a DC cannabis provision. The rider survives by being too small to fight over and too entrenched to remove.
- Harris chairs a key subcommittee. His position on the Agriculture Appropriations subcommittee gives him direct control over the section of the spending bill where the rider is inserted. Removing it requires overriding the subcommittee chair — something colleagues are reluctant to do on a provision that does not affect their own constituents.
- Bipartisan indifference. While many Democrats vocally support DC autonomy, the rider consistently receives bipartisan support in the final vote. Cannabis policy for a non-state jurisdiction is not a priority for most members.
The Rescheduling Wild Card
There is one scenario that could render the Harris Rider partially ineffective without Congress lifting a finger: federal rescheduling of cannabis.
The Harris Rider specifically prohibits DC from enacting laws regarding "any schedule I substance" and "any tetrahydrocannabinol derivative." If cannabis is rescheduled from Schedule I to Schedule III (as the DEA proposed in 2024), the "Schedule I" language would no longer apply to cannabis.
However, the rider also includes the phrase "tetrahydrocannabinol derivative," which is broader and does not reference a specific schedule. Legal scholars are divided on whether this secondary language would be sufficient to maintain the blockade even after rescheduling. The question has never been tested because rescheduling has not been finalized.
If cannabis moves to Schedule III and courts determine the "Schedule I" language no longer applies, DC could potentially regulate and tax cannabis sales. But the "THC derivatives" clause creates legal uncertainty. A definitive answer may require litigation — and Congress could simply rewrite the rider to close any loophole.
The Cost of the Rider
The Harris Rider's impact on Washington, DC is not abstract. It has measurable consequences:
- $0 in cannabis tax revenue for DC, while neighboring Maryland collects tens of millions annually from its $1.16B market
- $600 million in annual cannabis transactions flowing through the unregulated gifting economy with zero consumer protections
- No mandatory testing for recreational cannabis products — enforcement operations have found products contaminated with amphetamines, psilocybin, cocaine, and methamphetamine
- No zoning, licensing, or safety standards for gifting storefronts
- Continued racial disparities in enforcement, as the underground market concentrates in communities already disproportionately affected by the drug war
Official Sources
- U.S. Congress — Appropriations Bill Text
- Delegate Eleanor Holmes Norton — Official Site
- ABCA — Cannabis Regulations
- DC Council — Code and Legislation
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org